cefuroxime has been researched along with Critical Illness in 3 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to develop a new intravenous dosing strategy for cefuroxime in critically ill patients undergoing continuous venovenous hemofiltration with regional citrate anticoagulation (RCA-CVVH) by analyzing its extracorporeal removal and pharmacokinetic (PK) parameters." | 1.43 | Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid. ( Burgers, DM; Foudraine, NA; Janssen, PK; le Noble, JL; Neef, K, 2016) |
| "In this observational pharmacokinetic study, multiple blood samples were taken over one dosing interval of intravenous cefuroxime." | 1.40 | Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures. ( Carlier, M; De Waele, JJ; Lipman, J; Noë, M; Roberts, JA; Stove, V; Verstraete, AG, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlier, M | 1 |
| Noë, M | 1 |
| Roberts, JA | 1 |
| Stove, V | 1 |
| Verstraete, AG | 1 |
| Lipman, J | 1 |
| De Waele, JJ | 1 |
| Jensen, JU | 1 |
| Hein, L | 1 |
| Lundgren, B | 1 |
| Bestle, MH | 1 |
| Mohr, T | 1 |
| Andersen, MH | 1 |
| Løken, J | 1 |
| Tousi, H | 1 |
| Søe-Jensen, P | 1 |
| Lauritsen, AØ | 1 |
| Strange, D | 1 |
| Petersen, JA | 1 |
| Thormar, K | 1 |
| Larsen, KM | 1 |
| Drenck, NE | 1 |
| Helweg-Larsen, J | 1 |
| Johansen, ME | 1 |
| Reinholdt, K | 1 |
| Møller, JK | 1 |
| Olesen, B | 1 |
| Arendrup, MC | 1 |
| Østergaard, C | 1 |
| Cozzi-Lepri, A | 1 |
| Grarup, J | 1 |
| Lundgren, JD | 1 |
| Janssen, PK | 1 |
| Foudraine, NA | 1 |
| Burgers, DM | 1 |
| Neef, K | 1 |
| le Noble, JL | 1 |
1 trial available for cefuroxime and Critical Illness
| Article | Year |
|---|---|
Invasive Candida infections and the harm from antibacterial drugs in critically ill patients: data from a randomized, controlled trial to determine the role of ciprofloxacin, piperacillin-tazobactam, meropenem, and cefuroxime.
Topics: Age Factors; Aged; Anti-Bacterial Agents; APACHE; Candidiasis, Invasive; Cefuroxime; Ciprofloxacin; | 2015 |
2 other studies available for cefuroxime and Critical Illness
| Article | Year |
|---|---|
Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Computer Si | 2014 |
Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Topics: Aged; Anti-Bacterial Agents; Anticoagulants; Blood Coagulation; Cefuroxime; Citric Acid; Critical Il | 2016 |